We are live on
!
Find out more
KA
Kearns & Associates Portfolio holdings
AUM
$214M
1-Year Est. Return
23.8%
This Fund
S&P 500
This Quarter
Est. Return
-2.86%
1 Year Est. Return
+23.8%
3 Year Est. Return
+69.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$7.7M
(-4%)
Cap. Flow
-$1.4M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
89%
Holding
41
New
1
Increased
7
Reduced
9
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$437K |
| 2 |
Baker Hughes
BKR
|
+$217K |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$170K |
| 4 |
Schwab International Equity ETF
SCHF
|
+$57.7K |
| 5 |
Vanguard Small-Cap ETF
VB
|
+$10.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Herbalife
HLF
|
+$733K |
| 2 |
Royalty Pharma
RPRX
|
+$547K |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$388K |
| 4 |
Wells Fargo
WFC
|
+$150K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$149K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.82% |
| 2 | Financials | 3.48% |
| 3 | Healthcare | 1.88% |
| 4 | Communication Services | 1.48% |
| 5 | Consumer Discretionary | 0.52% |
Similar funds
TSS
CMBA
RC
ALS
GC
VCM
MCA
IH
Kearns & Associates's Q1 2026 Portfolio in Review
As of Q1 2026, Kearns & Associates held 41 positions worth $186M, down 4% from $194M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 4.9%. Kearns & Associates opened 1 new position and exited 1, leaving the 41-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 4.2% a quarter earlier, followed by Financials and Healthcare.
- Kearns & Associates's largest Q1 2026 buy was Baker Hughes: 3,750 shares worth $229K.
- Kearns & Associates added most to Vanguard FTSE Developed Markets ETF in Q1 2026, an estimated $437K increase.
- Kearns & Associates's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $547K.
- Kearns & Associates fully exited Herbalife in Q1 2026, selling an estimated $733K.
- Kearns & Associates's ten largest holdings make up 89% of its $186M portfolio in Q1 2026.
- Kearns & Associates opened 1 new position and closed 1 in Q1 2026.
- Kearns & Associates's portfolio value fell 4% quarter-over-quarter to $186M.
Based on Kearns & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.